View Alert


Originator: DHSC & NHS England and Improvement: Supply disruption alert

 
Issue date: 10-Jan-2020 10:51:13

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Social Care Providers (registered with CAS)
  • Special Health Authorities
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • DHSC Supply Disruption - Medicines

Action category: Action

Title: Phenytoin Sodium NRIM 100mg capsules - Supply Disruption Alert

Broadcast content:
Accord will be out of stock of phenytoin sodium 100mg capsules until early May 2020.

Phenytoin is classified by the Medicines and Healthcare products Regulatory Agency (MHRA) as a Category 1 anti-epileptic drug; for these drugs, prescribers are advised to ensure that their patient is maintained on a specific manufacturer’s product. 

An alternative phenytoin sodium 100mg capsules manufactured by Flynn Pharma is available, however switching to an alternative formulation requires monitoring and may also require specialist support, advice or referral.  

This alert contains advice on the management of affected patients.


Additional information: NHS Regional Offices: please cascade to community pharmacy.

Alert reference: SDA/2020/001

Action underway deadline: 14-Jan-2020

Action complete deadline: 08-May-2020

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency